Post-Authorization Safety Study (PASS): Investigating the occurrence of major bleedings in real life, in patients with atrial fibrillation (AF) treated with the combination of apixaban and dronedarone compared against patients on warfarin and dronedarone

Study protocol

Initial protocol

Study B0661075 Final Protocol 06-Apr-2016

English (2.89 MB - PDF) View document

Updated protocol

PASS Protokoll studie B0661075_FINAL 2016-10-18_amended 2017-05-05

First published: 22/02/2024

English (2.92 MB - PDF) View document

Study results

Apixadron NI PASS Study Report Final_shorter version to EU PAS Registry 2017-09-15_1-60

English (1.31 MB - PDF) View document

Study report

Other information

Secondary tabs